Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis

被引:0
|
作者
Miriam Blasi
Martin E. Eichhorn
Petros Christopoulos
Hauke Winter
Claus Peter Heußel
Felix J. Herth
Rami El Shafie
Katharina Kriegsmann
Mark Kriegsmann
Albrecht Stenzinger
Helge Bischoff
Michael Thomas
Jonas Kuon
机构
[1] Thoraxklinik at Heidelberg University Hospital,Department of Thoracic Oncology
[2] Translational Lung Research Center (TLRC) Heidelberg,Department of Thoracic Surgery
[3] Member of the German Center for Lung Research (DZL),Department of Diagnostic and Interventional Radiology With Nuclear Medicine
[4] Thoraxklinik at Heidelberg University Hospital,Department of Pneumology
[5] Thoraxklinik at Heidelberg University Hospital,Department of Radiation Oncology
[6] Thoraxklinik at Heidelberg University Hospital,Department of Hematology, Oncology and Rheumatology
[7] Heidelberg University Hospital,Institute of Pathology
[8] Heidelberg University Hospital,Department of Diagnostic and Interventional Radiology
[9] Heidelberg University Hospital,undefined
[10] University Hospital,undefined
来源
关键词
Adjuvant chemotherapy; Elderly; Non-small cell lung cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis
    Blasi, Miriam
    Eichhorn, Martin E.
    Christopoulos, Petros
    Winter, Hauke
    Heussel, Claus Peter
    Herth, Felix J.
    El Shafie, Rami
    Kriegsmann, Katharina
    Kriegsmann, Mark
    Stenzinger, Albrecht
    Bischoff, Helge
    Thomas, Michael
    Kuon, Jonas
    [J]. BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [2] Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer
    Tsutani, Yasuhiro
    Miyata, Yoshihiro
    Kushitani, Kei
    Takeshima, Yukio
    Yoshimura, Masahiro
    Okada, Morihito
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (04): : 1179 - 1185
  • [3] Selection for Adjuvant Chemotherapy in Stage IB Non-Small Cell Lung Cancer: A Propensity Score-Matched Analysis
    Jeon, Jae Hyun
    Moon, Duk Hwan
    Yang, Hee Chul
    Kim, Moon Soo
    Lee, Jong Mog
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S292 - S292
  • [4] Stage IV non-small cell lung cancer patients aged 75 years and older
    Tamura, T.
    Kurishima, K.
    Watanabe, H.
    Nakazawa, K.
    Ishikawa, H.
    Satoh, H.
    Hizawa, N.
    [J]. EUROPEAN GERIATRIC MEDICINE, 2015, 6 (01) : 31 - 35
  • [5] THE BENEFIT OF ADJUVANT CHEMOTHERAPY FOR PATIENTS AGED 75 OR OLDER WITH STAGE III COLON CANCER
    Chen, C. H.
    Yi-Jung, W.
    Lin, T. Y.
    [J]. VALUE IN HEALTH, 2019, 22 : S442 - S442
  • [6] Propensity score-matched comparison of robotic- and video-assisted thoracoscopic surgery, and open lobectomy for non-small cell lung cancer patients aged 75 years or older
    Pan, Hanbo
    Gu, Zenan
    Tian, Yu
    Jiang, Long
    Zhu, Hongda
    Ning, Junwei
    Huang, Jia
    Luo, Qingquan
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis
    Zhou, Ke
    Zhao, Yaqin
    Liang, Linchuan
    Cao, Jie
    Lin, Huahang
    Peng, Zhiyu
    Mei, Jiandong
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis
    Tatsugami, Katsunori
    Oya, Mototsugu
    Kabu, Koki
    Akaza, Hideyuki
    [J]. BRITISH JOURNAL OF CANCER, 2018, 119 (02) : 241 - 247
  • [9] Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis
    Katsunori Tatsugami
    Mototsugu Oya
    Koki Kabu
    Hideyuki Akaza
    [J]. British Journal of Cancer, 2018, 119 : 241 - 247
  • [10] Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older
    Furuta, M
    Hayakawa, K
    Katano, S
    Saito, Y
    Nakayama, Y
    Takahashi, T
    Imai, R
    Ebara, T
    Mitsuhashi, N
    Niibe, H
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (02) : 95 - 98